Marijn M Speeckaert Selected Research

Vitamin D-Binding Protein

12/2022	Influence of the vitamin D binding protein polymorphisms on the relationship between vitamin D status and the severity of COVID-19 in pregnant women.
1/2022	Vitamin D Binding Protein Polymorphism: a Potential Determinant of the Prevalence and Outcome of COVID-19.
1/2022	Vitamin D binding protein: A polymorphic protein with actin-binding capacity in COVID-19.
10/2021	Vitamin D binding protein and its polymorphisms may explain the link between vitamin D deficiency and COVID-19.
1/2021	A key role for vitamin D binding protein in COVID-19?
1/2021	Importance of the Lipid-Bound Character of Vitamin D Binding Protein in the Evaluation of Vitamin D Status in COVID-19 Patients.
1/2021	Genetic Polymorphisms in the Host and COVID-19 Infection.
1/2021	Vitamin D binding protein polymorphism and COVID-19.
1/2021	Contribution of Vitamin D-Binding Protein Polymorphism to Susceptibility and Outcome of COVID-19 Patients.
1/2021	Genetic polymorphisms, vitamin D binding protein and vitamin D deficiency in COVID-19.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marijn M Speeckaert Research Topics

Disease

22	COVID-19 12/2022 - 01/2020
9	Chronic Renal Insufficiency 03/2022 - 07/2013
7	Diabetes Mellitus 01/2021 - 01/2015
6	Kidney Diseases (Kidney Disease) 03/2022 - 03/2011
5	Inflammation (Inflammations) 03/2022 - 04/2017
4	Diabetic Nephropathies (Diabetic Nephropathy) 04/2022 - 01/2016
4	Infections 01/2022 - 01/2010
4	Fibrosis (Cirrhosis) 01/2022 - 01/2016
4	Atherosclerosis 01/2021 - 04/2017
4	Proteinuria 01/2020 - 07/2013
3	Vitamin D Deficiency 10/2021 - 01/2021
3	Neoplasms (Cancer) 01/2019 - 01/2013
3	Chronic Kidney Failure (Chronic Renal Failure) 04/2017 - 09/2008
3	Cystic Fibrosis (Mucoviscidosis) 11/2016 - 01/2008
3	IGA Glomerulonephritis (IGA Nephropathy) 06/2016 - 05/2013
2	Virus Diseases (Viral Diseases) 07/2022 - 01/2010
2	Cicatrix (Scar) 05/2022 - 04/2022
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021 - 01/2019
2	Parkinson Disease (Parkinson's Disease) 01/2020 - 01/2016
2	Carcinogenesis 01/2019 - 10/2012
2	Sepsis (Septicemia) 01/2019 - 12/2015
2	Albuminuria 08/2017 - 07/2013
2	Purpura 06/2016 - 05/2013
2	Nephritis 06/2016 - 05/2013
2	Scurvy (Scorbutus) 09/2013 - 11/2011
1	Urolithiasis 10/2022
1	Kidney Calculi (Kidney Stone) 10/2022
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 07/2022
1	Paraproteinemias (Monoclonal Gammopathy) 07/2022
1	Immune System Diseases (Immune Disorders) 07/2022
1	Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II) 07/2022
1	Keloid 05/2022
1	Hypertrophic Cicatrix (Hypertrophic Scar) 05/2022
1	Type 2 Diabetes Mellitus (MODY) 04/2022
1	Atrophy 01/2022
1	Giant Cell Arteritis (Horton Disease) 12/2021
1	Vasculitis (Vasculitides) 12/2021
1	Autism Spectrum Disorder 12/2021
1	Dysbiosis 11/2021
1	Obesity 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Disease Progression 07/2019
1	Rhabdomyolysis 01/2019
1	Wounds and Injuries (Trauma) 01/2019
1	Liver Diseases (Liver Disease) 01/2019
1	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2019
1	Renal Insufficiency (Renal Failure) 01/2018

Drug/Important Bio-Agent (IBA)

17	Vitamin D-Binding ProteinIBA 12/2022 - 01/2008
14	Proteins (Proteins, Gene)FDA Link 10/2022 - 10/2012
9	Vitamin D FDA LinkGeneric 12/2022 - 09/2008
9	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2012
7	AlbuminsIBA 01/2022 - 03/2011
5	CreatinineIBA 01/2022 - 12/2015
4	IronIBA 01/2021 - 01/2010
4	HaptoglobinsIBA 01/2021 - 01/2010
3	Complement System Proteins (Complement)IBA 07/2022 - 09/2017
2	Antigen-Antibody Complex (Immune Complex)IBA 07/2022 - 10/2015
2	SiliconesIBA 05/2022 - 04/2022
2	Silicone GelsIBA 05/2022 - 04/2022
2	Advanced Glycation End ProductsIBA 04/2022 - 03/2022
2	Uremic ToxinsIBA 11/2021 - 01/2018
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2021 - 01/2020
2	LipidsIBA 01/2021 - 03/2010
2	Biological ProductsIBA 01/2021 - 07/2013
2	25-hydroxyvitamin DIBA 01/2020 - 03/2016
2	Creatine Kinase (Creatine Phosphokinase)IBA 01/2019 - 10/2014
2	Glycoproteins (Glycoprotein)IBA 01/2018 - 01/2013
2	AntibodiesIBA 09/2017 - 10/2015
2	CytokinesIBA 04/2017 - 12/2015
2	ChemokinesIBA 04/2017 - 12/2015
2	metal transporting protein 1 (ferroportin)IBA 01/2017 - 11/2016
2	Immunoglobulin G (IgG)IBA 11/2016 - 10/2015
2	Fatty Acids (Saturated Fatty Acids)IBA 11/2016 - 10/2015
2	Immunoglobulin A (IgA)IBA 06/2016 - 10/2015
2	Blood Proteins (Serum Proteins)IBA 10/2015 - 01/2010
2	Ascorbic Acid (Vitamin C)FDA LinkGeneric 09/2013 - 11/2011
1	mesoglycanIBA 05/2022
1	Dietary Advanced Glycation End ProductsIBA 04/2022
1	Epidermal Growth Factor (EGF)IBA 01/2022
1	AA amyloidosisIBA 12/2021
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 12/2021
1	C-Reactive ProteinIBA 12/2021
1	Volatile Fatty AcidsIBA 11/2021
1	human esRAGE proteinIBA 01/2021
1	Receptor for Advanced Glycation End ProductsIBA 01/2021
1	Galactoside 2-alpha-L-fucosyltransferase (Fucosyltransferase 2)IBA 01/2021
1	Blood Group Antigens (Blood Groups)IBA 01/2021
1	Complement C3 (C3 Complement)IBA 01/2021
1	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 01/2021
1	molybdate (molybdate ion)IBA 01/2020
1	pyrogallol sulfonphthaleinIBA 01/2020
1	Hemoglobins (Hemoglobin)IBA 07/2019
1	Urea (Carbamide)FDA LinkGeneric 07/2019
1	Lipoproteins (Lipoprotein)IBA 05/2019
1	Growth Differentiation Factor 15IBA 01/2019
1	Bromcresol Green (Bromocresol Green)IBA 01/2018

Therapy/Procedure

3	Therapeutics 05/2022 - 07/2014
1	Inlays (Inlay) 04/2022
1	Renal Dialysis (Hemodialysis) 01/2020